James R. Kasinger

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James R. Kasinger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG General Counsel and Secretary Common Shares 83.4K $5.55M $66.60 14 Oct 2025 Direct
CRISPR Therapeutics AG General Counsel and Secretary Stock Option (Right to Buy) 16.5K 03 Oct 2025 Direct
CRISPR Therapeutics AG General Counsel and Secretary Restricted Stock Units 2.11K 13 Oct 2025 Direct

Insider Reports Filed by James R. Kasinger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRSP CRISPR Therapeutics AG 13 Oct 2025 3 -$71.7K 4 General Counsel and Secretary 15 Oct 2025, 17:35
CRSP CRISPR Therapeutics AG 03 Oct 2025 1 $0 4 General Counsel and Secretary 03 Oct 2025, 17:36
CRSP CRISPR Therapeutics AG 20 Mar 2025 3 -$131K 4 General Counsel and Secretary 24 Mar 2025, 17:35
CRSP CRISPR Therapeutics AG 14 Mar 2025 2 $0 4 General Counsel and Secretary 18 Mar 2025, 17:35
CRSP CRISPR Therapeutics AG 10 Mar 2025 6 -$169K 4 General Counsel and Secretary 12 Mar 2025, 19:05
CRSP CRISPR Therapeutics AG 16 Feb 2025 6 -$619K 4 General Counsel and Secretary 19 Feb 2025, 17:35
CRSP CRISPR Therapeutics AG 16 Oct 2024 2 $0 4 General Counsel and Secretary 18 Oct 2024, 17:35
CRSP CRISPR Therapeutics AG 13 Oct 2024 3 -$50.4K 4 General Counsel and Secretary 15 Oct 2024, 18:00
CRSP CRISPR Therapeutics AG 20 Mar 2024 2 $0 4 General Counsel and Secretary 22 Mar 2024, 17:45
CRSP CRISPR Therapeutics AG 10 Mar 2024 6 -$305K 4 General Counsel and Secretary 12 Mar 2024, 17:45
CRSP CRISPR Therapeutics AG 18 Feb 2024 3 -$152K 4 General Counsel and Secretary 21 Feb 2024, 17:45
CRSP CRISPR Therapeutics AG 13 Oct 2023 2 $0 4 General Counsel and Secretary 17 Oct 2023, 17:48
CRSP CRISPR Therapeutics AG 10 Mar 2023 8 -$99.6K 4 General Counsel and Secretary 14 Mar 2023, 17:45
CRSP CRISPR Therapeutics AG 18 Feb 2023 3 -$94.1K 4 General Counsel and Secretary 22 Feb 2023, 16:35
CRSP CRISPR Therapeutics AG 03 Dec 2022 3 -$169K 4 General Counsel and Secretary 06 Dec 2022, 16:47
CRSP CRISPR Therapeutics AG 07 Oct 2022 1 $0 4 General Counsel and Secretary 12 Oct 2022, 17:40
CRSP CRISPR Therapeutics AG 16 Aug 2022 1 $0 4 General Counsel and Secretary 18 Aug 2022, 17:33
CRSP CRISPR Therapeutics AG 10 Mar 2022 6 -$146K 4 General Counsel and Secretary 14 Mar 2022, 18:01
CRSP CRISPR Therapeutics AG 18 Feb 2022 2 $0 4 General Counsel and Secretary 22 Feb 2022, 16:40
CRSP CRISPR Therapeutics AG 03 Dec 2021 3 -$436K 4 General Counsel and Secretary 07 Dec 2021, 19:00
CRSP CRISPR Therapeutics AG 02 Dec 2021 2 $100K 4 General Counsel and Secretary 03 Dec 2021, 19:00
CRSP CRISPR Therapeutics AG 15 Oct 2021 1 $0 4 General Counsel and Secretary 18 Oct 2021, 20:00
CRSP CRISPR Therapeutics AG 10 Sep 2021 3 -$559K 4 General Counsel and Secretary 14 Sep 2021, 21:45